To note, all 24 ultrahigh ERBB2 CN status cases were clinically Ki67 high (p = 0.016, chi-square test), but there was no association to any other clinicopathological variables (age, lymph nodes, tumor size, hormone receptors, or grade). This evidence concerns the gene NR4A1 and neoplasm.